Gastrografin (Bracco Diagnostics Inc)


Welcome to the PulseAid listing for the Gastrografin drug offered from Bracco Diagnostics Inc. This Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA],Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Bracco Diagnostics Inc
NON-PROPRIETARY NAME: diatrizoate meglumine and diatrizoate sodium
SUBSTANCE NAME: DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA],Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA]
ROUTE: ORAL; RECTAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1958-02-26
END MARKETING DATE: 0000-00-00


Gastrografin HUMAN PRESCRIPTION DRUG Details:

Item DescriptionGastrografin from Bracco Diagnostics Inc
LABELER NAME: Bracco Diagnostics Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 660; 100(mg/mL; mg/mL)
START MARKETING DATE: 1958-02-26
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0270-0445_c0afca1c-73d2-1224-0684-682ca346e7bb
PRODUCT NDC: 0270-0445
APPLICATION NUMBER: NDA011245

Other DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Bracco Diagnostics IncGastrografin
Liebel-Flarsheim Company LLCMD-76R